Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

5-Alpha Reductase and Anabolic Effects of Testosterone

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00475501
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:07.674584+00:00
Published At
2014-07-31T00:00:00+00:00
Record Updated At
2018-10-11
Results Posted At
2014-07-31
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Male Hypogonadism", "Muscle Atrophy", "Sarcopenia", "Benign Prostate Hypertrophy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-10-11"
protocolSection.identificationModule.nctId
"NCT00475501"
protocolSection.identificationModule.officialTitle
"5-Alpha Reductase and Anabolic Effects of Testosterone"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2014-07-31"

Study condition terms

  • Male Hypogonadism (protocolSection.conditionsModule.conditions)
  • Muscle Atrophy (protocolSection.conditionsModule.conditions)
  • Sarcopenia (protocolSection.conditionsModule.conditions)
  • Benign Prostate Hypertrophy (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.